The government will push for a revision of the law that will put a brake on the suspension of execution filed by pharmaceutical companies in drug price lawsuits. If companies fight against the government over drug prices and finally win the case, the insurer will refund the drug cost equivalent to the loss so far. This is a revision of the legal unit, so it is highly likely to take effect immediately. The revision bill will three times shorten the negotiation period for the reduction of the original drug price of patent expiration, and includes amendments to omit drugs with a history of negotiations in the future.

The MOHW announced today (17th) the "Partial Amendment to the Rules on the standards of natio